CompletedPhase 2NCT02530320
Safety and Efficacy of PD0332991 (Palbociclib), a Cyclin-dependent Kinase 4 and 6 Inhibitor, in Patients With Oligodendroglioma or Recurrent Oligoastrocytoma Anaplastic With the Activity of the Protein RB Preserved
Studying Oligodendroglioma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Grupo Español de Investigación en Neurooncología
- Principal Investigator
- Juan Manuel SepúlvedaH. 12 de Octubre
- Intervention
- Palbociclib(drug)
- Enrollment
- 34 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2015 – 2020
Study locations (11)
- Hospital Insular de Canarias, Las Palmas de Gran Canaria, Las Palmas, Spain
- Hospital Son Espases, Palma de Mallorca, Mallorca, Spain
- Consorcio Hospitalario Provincial de Castellón, Castellon, Valencia, Spain
- Hospital Clínic de Barcelona, Barcelona, Spain
- ICO Hospitalet, Barcelona, Spain
- Hospital de León, León, Spain
- Hospital 12 de Octubre, Madrid, Spain
- Hospital Ramón y Cajal, Madrid, Spain
- Hospital Regional de Málaga, Málaga, Spain
- Hospital Virgen del Rocio, Seville, Spain
- Hospital Universitario y Politécnico La Fe, Valencia, Spain
Collaborators
Pfizer
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02530320 on ClinicalTrials.govOther trials for Oligodendroglioma
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06989086FearLess in NeuroOncologyVirginia Commonwealth University
- ACTIVE NOT RECRUITINGPHASE1NCT06254326ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult PatientsUniversity of Florida
- RECRUITINGPHASE2NCT05512351Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNAlevel- Relapse and Clinical-relapse OligodendrogliomaHenan Provincial People's Hospital
- RECRUITINGNANCT05190172PRO-GLIO: PROton Versus Photon Therapy in IDH-mutated Diffuse Grade II and III GLIOmasOslo University Hospital
- RECRUITINGPHASE3NCT04702581A Randomized Trial of Delayed Radiotherapy in Patients Low-grade Oligodendrogliomas Requiring a Treatment Other Than SurgeryHospices Civils de Lyon
- RECRUITINGPHASE3NCT05331521A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed Brain Tumors (Gliomas).University Hospital Heidelberg
- ACTIVE NOT RECRUITINGPHASE2NCT03969706Abemaciclib in Patients with OligodendrogliomaStephen Bagley, MD, MSCE